Colgate-Palmolive: A Resilient Dividend King Worth Considering
Money

Colgate-Palmolive: A Resilient Dividend King Worth Considering

authorBy Dave Ramsey
DateJul 03, 2026
Read Time3 min

Colgate-Palmolive stands out as a compelling choice for investors prioritizing consistent income and long-term growth. With an unbroken dividend streak since 1895 and 64 consecutive years of dividend increases, the company exemplifies financial fortitude. Despite prevailing economic headwinds, particularly inflationary pressures impacting material costs, Colgate-Palmolive has managed to sustain robust sales growth and maintain its full-year guidance. Its established market position, coupled with strategic investments in innovation and efficiency, underpins its enduring appeal as a defensive yet dynamic investment.

Colgate-Palmolive Navigates Economic Headwinds with Strong Dividend Performance and Sales Growth

As of July 3, 2026, Colgate-Palmolive Company (NYSE: CL), a renowned name in consumer staples, continues to impress investors with its steadfast performance. The company, celebrated for its wide array of products including cleaning supplies, personal care items, and pet food, has achieved an impressive 16% stock appreciation year-to-date, alongside offering a dividend yield exceeding 2%. This performance solidifies its status as a 'Dividend King', a title reserved for companies that have increased their dividends for at least half a century, a feat Colgate-Palmolive has surpassed with 64 years of consecutive dividend hikes and uninterrupted payouts dating back to 1895.

Recently, Colgate-Palmolive announced a quarterly dividend increase to $0.53 per share, a payout generously supported by its substantial free cash flow, which hovers around $3.6 billion. The company reported a significant 8.4% rise in net sales for the first quarter of 2026, successfully reaffirming its ambitious full-year guidance despite a challenging economic landscape.

The primary hurdle confronting Colgate-Palmolive remains the persistent inflationary pressures on raw materials. This challenge led to a decrease in both earnings per share and gross profit margin during the first quarter. However, the company's formidable pricing power and widespread global brand recognition act as crucial stabilizers. Furthermore, strategic investments in technological advancements aim to foster innovation and enhance operational efficiency, mitigating these cost pressures.

For investors focused on long-term income, Colgate-Palmolive offers a unique blend of defensive stability and growth potential. Although its current forward P/E ratio of approximately 24 and a valuation of about three times company sales might suggest a slight overvaluation, its historical resilience and consistent dividend record make it an attractive proposition for those planning to buy and hold. This global consumer staple powerhouse should not be overlooked by savvy investors.

Colgate-Palmolive's consistent performance and commitment to shareholder returns offer a valuable lesson in long-term investing. In an unpredictable market, companies with strong fundamentals, global brand recognition, and a history of navigating economic challenges demonstrate remarkable resilience. This case highlights the importance of focusing on businesses that not only deliver consistent profits but also reward investors through reliable dividends, underscoring that stability can be a powerful engine for sustained growth.

More Articles
Money
Mineralys Therapeutics' $500 Million Financing Fuels Growth and Potentially Skyrockets Stock Value
Mineralys Therapeutics (MLYS) recently secured up to $500 million in financing and renegotiated its agreement with Tanabe Pharma for full global rights to lorundrostat, its key drug candidate. These strategic moves, combined with a 'Buy' rating from Goldman Sachs, position MLYS for significant growth in addressing cardiorenal conditions, potentially turning it into a multibagger stock despite increased debt obligations.
By Mr. Money MustacheJul 03, 2026
Money
Comparing VT and SCHF: A Deep Dive into International ETF Options
This article explores the differences between the Vanguard Total World Stock ETF (VT) and the Schwab International Equity ETF (SCHF), two prominent options for investors seeking global diversification. It examines their cost-effectiveness, income generation, and underlying holdings, offering insights into which ETF might be a better fit depending on an investor's portfolio strategy and desired exposure to international markets.
By Mr. Money MustacheJul 03, 2026
Money
Vltava Fund Exits Cenovus Energy After Significant Gains, Citing Market Overvaluation
Vltava Fund, an investment firm, divested its stake in Cenovus Energy Inc. during Q2 2026. The firm noted substantial profits from its investment in the Canadian energy company, primarily driven by geopolitical events affecting oil prices. Despite Cenovus's strong performance, Vltava Fund deemed its stock price to be overvalued relative to its intrinsic value, emphasizing a strategy to capitalize on market cyclicality in the energy sector and potentially re-enter under more favorable conditions.
By Mr. Money MustacheJul 03, 2026
Money
Analyst Optimism Surrounds Resideo Technologies' Multibagger Potential
Seaport Research has initiated coverage on Resideo Technologies Inc. (REZI) with a 'Buy' rating and a $55 price target, signaling a significant upside potential of 76%. This positive outlook stems from key developments, including a renegotiated parent company agreement projected to boost annual cash flow by $140 million and the upcoming spin-off of its lower-margin distribution arm. Despite a soft consumer electronics market, Resideo's resilient security and safety product segments are expected to drive growth, even amidst a slower housing market.
By T. Harv EkerJul 03, 2026
Money
A Comparative Analysis of Leading Broad Market ETFs
This article delves into a detailed comparison of two prominent broad market ETFs: the Schwab U.S. Broad Market ETF (SCHB) and the State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF (SPTM). It examines their investment objectives, expense ratios, dividend yields, holdings, and long-term performance to help investors make informed decisions. Both ETFs offer cost-effective exposure to the U.S. equity market, with slight variations in the breadth of their underlying indices.
By JL CollinsJul 03, 2026